Market Currents
Salix Pharmaceuticals (SLXP): Q3 EPS of $0.95 beats by $0.25. Revenue of $185.1M (+26.6% Y/Y)...
-
Wednesday, November 7, 2012, 4:41 PM ETSalix Pharmaceuticals (SLXP): Q3 EPS of $0.95 beats by $0.25. Revenue of $185.1M (+26.6% Y/Y) misses by $2M. Shares +8.4% AH. (PR)
Other date
Latest Earnings Articles
